hotspot -WSS

hotspot

author：leisure time 2025-09-03 03:29:15 - browse：9983

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Novo Nordisk obesity pill bests Wegovy in early trial

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Health AI: on the border between health care and tech

Illumina slashes 2023 revenue projections yet again

Bird flu researchers hone in on Finland’s mink farms

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

knowledge

hotspot

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The problem with charging patients to message their doctors

How to save PrEP access — and even expand it

After Optum profits sink, UnitedHealth makes changes

United colonoscopy coverage change 'may cost lives,' doctors say

Timeline: How the deadly wildfires took over Maui day by day

As demand for Covid shots wanes, Moderna seeks its next success

Change Healthcare payments predicted restored March 15

Hepatitis C has a cure — but many Americans still lack access to it

Hospitals are dialing back on venture capital investing

focus

Amylyx ALS drug fails large clinical trial

What it’s like to watch children die of measles

Just how do doctors, lawmakers, and the public define abortion?

Health AI: on the border between health care and tech

Mark Cuban is blaming the wrong people for high drug costs

Timeline: How the deadly wildfires took over Maui day by day

hotspot

Wikipedia

knowledge

hotspot